0001209191-21-043702.txt : 20210629 0001209191-21-043702.hdr.sgml : 20210629 20210629171400 ACCESSION NUMBER: 0001209191-21-043702 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210629 DATE AS OF CHANGE: 20210629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Rachel K. CENTRAL INDEX KEY: 0001589712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 211059130 MAIL ADDRESS: STREET 1: C/O GLYCOMIMETICS, INC. STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-25 0 0001000694 NOVAVAX INC NVAX 0001589712 King Rachel K. C/O NOVAVAX, INC. 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 0 0 0 Common Stock 2021-06-25 4 M 0 6900 A 9700 D Common Stock 1100 I See Footnote Common Stock 1100 I See Footnote Restricted Stock Units 2021-06-25 4 M 0 6900 0.00 D Common Stock 6900 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child. Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date. /s/ John A. Herrmann III, Attorney-in-Fact 2021-06-29